Epidemiology and clinical course of COVID-19 in Shanghai, China.
Yinzhong ShenFang ZhengDanfeng SunYun LingJun ChenFeng LiTao LiZhiping QianYuyi ZhangQingnian XuLi LiuQin HuangFei ShanLie XuJun WuZhaoqin ZhuZhigang SongShenyang LiYuxin ShiJianliang ZhangXueyun WuJoshua B MendelsohnTongyu ZhuHongzhou LuPublished in: Emerging microbes & infections (2020)
Background: Novel coronavirus pneumonia (COVID-19) is prevalent around the world. We aimed to describe epidemiological features and clinical course in Shanghai. Methods: We retrospectively analysed 325 cases admitted at Shanghai Public Health Clinical Center, between January 20 and February 29, 2020. Results: 47.4% (154/325) had visited Wuhan within 2 weeks of illness onset. 57.2% occurred in 67 clusters; 40% were situated within 53 family clusters. 83.7% developed fever during the disease course. Median times from onset to first medical care, hospitalization and negative detection of nucleic acid by nasopharyngeal swab were 1, 4 and 8 days. Patients with mild disease using glucocorticoid tended to have longer viral shedding in blood and feces. At admission, 69.8% presented with lymphopenia and 38.8% had elevated D-dimers. Pneumonia was identified in 97.5% (314/322) of cases by chest CT scan. Severe-critical patients were 8% with a median time from onset to critical disease of 10.5 days. Half required oxygen therapy and 7.1% high-flow nasal oxygen. The case fatality rate was 0.92% with median time from onset to death of 16 days. Conclusion: COVID-19 cases in Shanghai were imported. Rapid identification, and effective control measures helped to contain the outbreak and prevent community transmission.
Keyphrases
- risk factors
- coronavirus disease
- sars cov
- public health
- nucleic acid
- computed tomography
- emergency department
- healthcare
- end stage renal disease
- ejection fraction
- respiratory syndrome coronavirus
- newly diagnosed
- loop mediated isothermal amplification
- mental health
- magnetic resonance imaging
- early onset
- magnetic resonance
- patient reported outcomes
- dual energy
- bone marrow
- mesenchymal stem cells
- smoking cessation
- replacement therapy
- chemotherapy induced